Liquid Biopsy Market Recent Trends with Demand 2030

The global liquid biopsy market size is expected to reach USD 7,645.0 Million in 2030 and register a revenue CAGR of 20.3% over the forecast period, according to the latest analysis by Emergen Research. Rise in demand for early cancer detection is a key factor driving global liquid biopsy market revenue growth.

Liquid biopsy is a safe and popular procedure carried out during examination of cancer. The procedure is easy and minimally invasive, allows early detection and diagnosis of cancer, and helps in identification of cancer treatment. In addition, growing popularity of non-invasive techniques is driving private and public financing for research in the field of liquid biopsy, which allow medical professionals to discover various aspects of a tumor through a patient’s blood sample. It facilitates medical professionals to understand, which treatments are suitable for patients.



Get a sample of the report @ https://www.emergenresearch.com/request-sample/34

Radical Highlights of the Liquid Biopsy Market Report:

·     Comprehensive overview of the Liquid Biopsy market along with analysis of the changing dynamics of the market

·        Growth Assessment of various market segments throughout the forecast period

·    Regional and global analysis of the market players, including their market share and global position

·  Growth strategies adopted by key market players to combat the impact of the COVID-19 pandemic on the market

·    Impact of the technological developments and R&D advancements on the Liquid Biopsy market

·     Information about profit-making strategies and developmental strategies of major companies and manufacturers

·        Insightful information for the new entrants willing to enter the market

·   Details and insights about business expansion strategies, product launches, and other collaborations

·        The report incorporates advanced analytical tools such as SWOT analysis, Porter’s Five Forces Analysis, feasibility analysis, and investment return analysis

 

Key Companies Profiled in the Report:

Some companies in the global market report include Bio-Rad Laboratories, Inc., Adaptive Biotechnologies, NeoGenomics Laboratories, Guardant Health, Biocept, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., MDxHealth, Menarini Silicon Biosystems, and Agena Bioscience, Inc.

Market Dynamics:

The report offers insightful information about the market dynamics of the Liquid Biopsy market. It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Liquid Biopsy market, competitive landscape, factors affecting it, and to predict the growth of the industry. It also offers the impact of various market factors along with the effects of the regulatory framework on the growth of the Liquid Biopsy market.

Regional Landscape section of the Liquid Biopsy report offers deeper insights into the regulatory framework, current and emerging market trends, production and consumption patterns, supply and demand dynamics, import/export, and presence of major players in each region.

The various regions analyzed in the report include:

·        North America (U.S., Canada)

·        Europe (U.K., Italy, Germany, France, Rest of EU)

·        Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

·        Latin America (Chile, Brazil, Argentina, Rest of Latin America)

·        Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/34

Emergen Research has segmented the global liquid biopsy market based on product type, circulating biomarkers, sample type, technology, disease, application, end-use, and region:

  • Product Type Outlook (Revenue, USD Million; 2019–2030)
    • Assays Kits
    • Instruments
    • Services
  • Circulating Biomarkers Outlook (Revenue, USD Million; 2019–2030)
    • Circulating Tumor DNA (ctDNA)
    • Circulating Tumor Cells (CTCs)
    • Extracellular Vesicles (EVs)
    • Cell-Free DNA (cfDNA)
    • Others
  • Sample Type Outlook (Revenue, USD Million; 2019–2030)
    • Blood Sample
    • Urine Sample
    • Others
  • Technology Outlook (Revenue, USD Million; 2019–2030)
    • Multi-gene-parallel Analysis (NGS)
    • Single Gene Analysis (PCR Microarrays)
  • Disease Outlook (Revenue, USD Million; 2019–2030)
    • Oncology

1.     Breast Cancer

2.     Lung Cancer

3.     Prostate Cancer

4.     Colorectal Cancer

5.     Melanoma Cancer

6.     Others

    • Non-cancer
  • Application Outlook (Revenue, USD Million; 2019–2030)
    • Early Cancer Screening
    • Therapy Selection
    • Treatment Monitoring
    • Recurrence Monitoring Orthopedics
  • End-Use Outlook (Revenue, USD Million; 2019–2030)
    • Hospitals & Physician Laboratories
    • Reference Laboratories
    • Academic & Research Centers
    • Others

Research Report on the Liquid Biopsy Market Addresses the Following Key Questions:

·        Who are the dominant players of the Liquid Biopsy market?

·      Which regional market is anticipated to have a high growth rate over the projected period?

·     What consumer trends and demands are expected to influence the operations of the market players in the Liquid Biopsy market?

·  What are the key growth drivers and restraining factors of the Liquid Biopsy market?

·  What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?

·   What is the overall impact of the COVID-19 pandemic on the Liquid Biopsy market and its key segments?

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/liquid-biopsy-market

Thank you for reading our report. Customization of this report is available in chapter-wise or region-wise sections. Kindly get in touch with us to know more about the report, and our team will provide excellent assistance.

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

 

 

Comments

Post a Comment